Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women

JAMA

Volumn 292, Issue 10, 2004, Pages 1179-1187

  Wessel, Timothy R ^a   Arant, Christopher B ^a   Olson, Marian B ^b   Johnson, B Delia ^b   Reis, Steven E ^b   Sharaf, Barry L ^c   Shaw, Leslee J ^d   Handberg, Eileen ^a   Sopko, George ^e   Kelsey, Sheryl F ^b   Pepine, Carl J ^a   Merz, C Noel Bairey ^f  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c RHODE ISLAND HOSPITAL   (United States)

^d Atlanta Cardiovasc Res Institute   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ESTROGEN; GESTAGEN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ANTHROPOMETRY; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CORONARY RISK; DUAL ENERGY X RAY ABSORPTIOMETRY; DYSLIPIDEMIA; FEMALE; FITNESS; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM; SELF REPORT; SEX DIFFERENCE; SIDE EFFECT; STROKE; UNSTABLE ANGINA PECTORIS;

EID: 4444265592     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.292.10.1179     Document Type: Article

References (42)

1. Manson JE, Skerrett PJ, Greenland P, Vanltallie TB. The escalating pandemics of obesity and sedentary lifestyle: a call to action for clinicians. Arch Intern Med. 2004:164:249-258.
2. Mosca L, Appel LJ, Benjamin EJ. et al. Evidence-based guidelines for cardiovascular disease prevention in women. Circulation. 2004;109:672-693.
3. Flegal KM. Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adute, 1999-2000. JAMA. 2002;288:1723-1727.
4. Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003;115(suppl 8A):37S-41S.
5. Kanaya AM, Vittinghoff E, Shlipak MG. et al. Association of total and central obesity with mortality in postmenopausal women with coronary heart disease. Am J Epidemiol. 2003;158:1161-1170.
6. Pradhan AD, Skerrett PJ, Manson JE. Obesity, diabetes, and coronary risk in women. J Cardiovasc Risk. 2002;9:323-330.
7. Kannel WB, Wilson PW, Nam BH, D'Agostino RB. Risk stratification of obesity as a coronary risk factor. Am J Cardiol. 2002;90:697-701.
8. Johansson S, Wilhelmsen L, Lappas G, Rosengren A, High lipid levels and coronary disease in women in Göteborg-outcome and secular trends: a prospective 19 year follow-up in the BEDA*study. Eur Heart J. 2003;24:704-716.
9. Huang KC, Lin WY, Lee LT, et al. Four anthropometric indices and cardiovascular risk factors in Taiwan. Int J Obes Relat Metab Disord 2002;26:1060-1068.
10. Halcox J, Zalos G, Charakida M, Quyyumi AA. Obesity predicts coronary endothelial dysfunction independently of inflammation, atherosclerosis, and conventional risk factors. J Am Coll Cardiol. 2004;43 (suppl A):485A,
11. Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation. 2003;108:2206-2211.
12. Jonsson S, Hedblad B, Engstrom G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk: twenty-three-year follow-up of 22,025 men from an urban Swedish population, Int J Obes Relat Metab Disord. 2002;26:1046-1053.
13. Rea TD, Heckbert SR, Kaplan RC, et al. Body mass index and the risk of recurrent coronary events following acute myocardial infarction. Am J Cardiol. 2001;88:467-472.
14. Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation. 2003;108:1554-1559.
15. Mora S, Redberg RF, Cui Y, et al. Ability of exercise testing to predict cardiovascular and all-cause death in asymptomatic women: a 20-year follow-up of the lipid research clinics prevalence study. JAMA. 2003;290:1600-1607.
16. Manson JE, Greenland P, LaCroix AZ, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002;347:716-725.
17. Stevens J, Cai J, Evenson KR, Thomas R. Fitness and fatness as predictors of mortality from all causes and from cardiovascular disease in men and women in the lipid research clinics study. Am J Epidemiol. 2002;156:832-841.
18. Merz CN, Olson MB, McGorray SP, Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study. J Womens Health Gend Based Med. 2000;9:769-777.
19. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002;23:706-713.
20. Hedblad S, Jonsson S, Nilsson P, Engstrom G, Berglund G, Janzon L. Obesity and myocardial infarction-vulnerability related to occupational level and marital status: a 23-year follow-up of an urban male Swedish population. J Intern Med. 2002;252:542-550.
21. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999;282:1547-1553.
22. Merz CN, Kelsey SF, Pepine CJ, et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. J Am Coll Cardiol. 1999;33:1453-1461.
23. Sharaf BL, Pepine CJ, Kerensky RA, et al. Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). Am J Cardiol. 2001;87:937-941; A933.
24. Bairey Merz CN, Olson MB, Johnson BD, et al. Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE). Am J Med. 2002;113:723-727.
25. Kip KE, Marroquin OC, Kelley DE, et al. Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation. 2004;109:706-713.
26. Bertsias G, Mammas I, Linardakis M, Kafatos A. Overweight and obesity in relation to cardiovascular disease risk factors among medical students in Crete, Greece. BMC Public Health. 2003;3:3.
27. Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989;64:651-654.
28. Writing Group for the PEPI. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA. 1996;276:1389-1396.
29. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
30. Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardial. 2001;37:1523-1528.
31. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA. 2003;289:1799-1804.
32. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation. 2002;105:804-809.
33. Tchernof A, Nolan A, Sites CK, Ades PA, Poehlman ET. Weight loss reduces C-reactive protein levels in obese postmenopausal women. Circulation. 2002;105:564-569.
34. Pischon T, Hankinson SE, Hotamisligil GS, Rifai N, Rimm EB. Leisure-time physical activity and reduced plasma levels of obesity-related inflammatory markers. Obes Res. 2003;11:1055-1064.
35. Schunkert H. Obesity and target organ damage: the heart, Int J Obes Relat Metab Disord. 2002;26 (suppl 4):S15-S20.
36. Okura T, Tanaka K, Nakanishi T, et al. Effects of obesity phenotype on coronary heart disease risk factors in response to weight loss. Obes Res. 2002;10:757-766.
37. Calle EE. Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med. 1999;341:1097-1105,
38. Olson MB, Kelsey SF, Bittner V, et al. Women's Ischemia Syndrome Evaluation Study Group. Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. J Am Coll Cardiol. 2000;36:1565-1571,
39. Hambrecht R, Walther C, Möbius-Winkler S, et al. Percutaneous coronary angioplasty compared with exercise training in patients with stable coronary artery disease: a randomized trial. Circulation. 2004;109:1371-1378.
40. Oldridge NB, Guyatt GH, Fischer ME, et al. Cardiac rehabilitation after myocardial infarction: combined experience of randomized clinical trials. JAMA. 1988;260:945-950.
41. Taylor RW, Keil D, Gold EJ, et al. Body mass index, waist girth, and waist-to-hip ratio as indexes of total and regional adiposity in women: evaluation using receiver operating characteristic curves. Am J Clin Nutr. 1998;67:44-49.
42. Raikkonen K, Matthews KA, Kuller LH, et al. Anthropometric and psychosocial determinants of visceral obesity in healthy postmenopausal women, Int J Obes. 1999;23:775-782.